EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: EF5 may detect the presence of oxygen in tumor cells and help plan effective
cancer treatment.
PURPOSE: Phase I trial to study the effectiveness of EF5 in detecting the presence of oxygen
in tumor cells of patients who are undergoing surgery or biopsy for breast, prostate, or
cervical cancer or high grade soft tissue sarcoma.